2m 2m 2m 2m 2m 2m 2m
Cresco Labs-SV (CRLBF)
OTC
$0.82-$0.03 (-3.53%)
Price as of Jun 12, 2026- $301.1MMarket Cap
- 64.66%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Cresco Labs-SV (CRLBF)
$0.82-$0.03 (-3.53%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 655.8M -9.46% | 724.3M -6.04% | 770.9M -8.52% | 842.7M N/A | |
Cost of Revenue | 331.3M -7.95% | 359.9M -11.90% | 408.5M -6.23% | 435.7M N/A | |
Gross Profit | 324.6M -10.94% | 364.5M +0.58% | 362.4M -10.97% | 407.0M +0.16% | |
Sales and Marketing Expense | 247.5M -2.90% | 254.8M -14.82% | 299.2M -14.68% | 350.7M +10.34% | |
Research and Development Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Depreciation and Amortization Expense | 48.7M -17.57% | 59.1M -5.46% | 62.5M +20.38% | 51.9M N/A | |
Total Operating Expenses | 352.6M +37.09% | 257.2M -14.04% | 299.2M -14.68% | 350.7M +10.34% | |
Operating Profit | -28.0M -126.08% | 107.3M +222.17% | -87.8M +4.19% | -84.3M N/A | |
Interest Income | 3.7M +5,305.56% | -72,000 N/A | N/A N/A | N/A N/A | |
Interest Expense | -56.3M +0.54% | -56.0M -7.96% | -60.8M +5.16% | -57.8M +12.94% | |
Interest Income and Expense and Net | -52.5M -6.28% | -56.1M -7.84% | -60.8M +5.16% | -57.8M -212.94% | |
Total Nonoperating Income and Expense | -67.4M -42.81% | -117.9M -293.87% | 60.8M +5.16% | 57.8M +12.94% | |
Income before Taxes | -95.4M +798.85% | -10.6M -94.10% | -179.9M -16.67% | -215.8M -27.28% | |
Income Taxes | 44.6M -10.53% | 49.9M +51.36% | 33.0M -62.95% | 88.9M N/A | |
Extraordinary Items | 105.1M +4,430.22% | 2.3M N/A | N/A N/A | N/A N/A | |
Net Income | -135.4M +81.91% | -74.4M -58.61% | -179.9M -16.67% | -215.8M -27.28% | |
Net Income from Continuing Operations Applicable to Common | -95.4M +798.85% | -10.6M -94.10% | -179.9M -16.67% | -215.8M -27.28% | |
Basic EPS and Net Income | -0.38 +72.73% | -0.22 -59.26% | -0.54 -23.94% | -0.71 -41.80% | |
Diluted EPS and Net Income | -0.38 +72.73% | -0.22 -59.26% | -0.54 -23.94% | -0.71 -41.80% | |
Basic Weighted Average Shares | 355.0M +2.76% | 345.5M +6.69% | 323.8M +8.61% | 298.2M +13.66% | |
Diluted Weighted Average Shares | 355.0M +2.76% | 345.5M +6.69% | 323.8M +8.61% | 298.2M +13.66% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 57.9M -57.91% | 137.6M +33.00% | 103.4M -13.33% | 119.3M N/A | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 57.9M -57.91% | 137.6M +33.00% | 103.4M -13.33% | 119.3M N/A | |
Total Current Assets | 259.3M -11.89% | 294.3M +5.81% | 278.1M -14.71% | 326.0M N/A | |
Accumulated Depreciation | 185.1M +13.98% | 162.4M N/A | N/A N/A | N/A N/A | |
Property and Plant and Equipment and Net | 327.2M -5.12% | 344.8M -6.37% | 368.3M -3.01% | 379.7M N/A | |
Total Long-Term Assets | 938.0M -11.60% | 1.1B -1.78% | 1.1B -14.10% | 1.3B -7.44% | |
Total Assets | 1.2B -11.66% | 1.4B -0.23% | 1.4B -14.22% | 1.6B -11.05% | |
Income Taxes Payable | 33.6M -14.45% | 39.3M N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | 10.8M -9.64% | 11.9M N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 100.2M +6.19% | 94.3M -52.89% | 200.2M -28.71% | 280.9M +194.28% | |
Total Long-Term Debt | 417.1M -9.47% | 460.8M N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 844.6M -3.23% | 872.8M +19.54% | 730.2M +2.10% | 715.1M N/A | |
Total Liabilities | 944.8M -2.31% | 967.2M +3.95% | 930.4M -6.59% | 996.0M +1.35% | |
Retained Earnings | -1.5B +10.92% | -1.4B +6.87% | -1.3B +17.59% | -1.1B +27.83% | |
Total Stockholders Equity | 340.4M -28.30% | 474.9M +10.93% | 428.1M -27.16% | 587.7M N/A | |
Total Shares Outstanding | 500,000 -99.86% | 349.1M +2.61% | 340.2M +12.75% | 301.7M N/A | |
Cash Flow | |||||
Cash from Operating Activities | 72.9M -44.98% | 132.5M +126.21% | 58.6M +212.49% | 18.7M N/A | |
Capital Expenditures | 35.1M +80.27% | 19.5M N/A | N/A N/A | N/A N/A | |
Cash from Investing Activities | -40.7M +61.34% | -25.2M -43.41% | -44.6M +21.89% | -36.6M N/A | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | -82.1M +14.84% | -71.5M +165.65% | -26.9M -68.94% | -86.6M N/A | |
Financials Ratio | |||||
Gross Margin | 49.49% -1.64% | 50.32% +7.04% | 47.01% -2.68% | 48.30% N/A | |
Operating Margin | -4.27% -128.81% | 14.81% +230.02% | -11.39% +13.89% | -10.00% N/A | |
Return on Assets | -10.61% +93.39% | -5.49% -55.13% | -12.23% -4.72% | -12.83% N/A | |
Return on Equity | -33.22% +101.46% | -16.49% -53.44% | -35.41% N/A | N/A N/A | |
Revenue Growth | -9.46% +56.63% | -6.04% -29.14% | -8.52% N/A | N/A N/A | |
Current Ratio | 2.59 -17.03% | 3.12 +124.60% | 1.39 +19.63% | 1.16 N/A | |
Cash Ratio | 0.58 -60.36% | 1.46 +182.32% | 0.52 +21.56% | 0.42 N/A | |
Debt-to-Equity Ratio | 1.26 +26.26% | 1.00 N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.36 +2.47% | 0.35 N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow